by John Conrad | Mar 27, 2023 | iBIO News
The Illinois Biotechnology Innovation Organization (iBIO), the trade association that represents the 91,000 jobs in Illinois’ life sciences sector, today announced the addition of two new members to its board of directors: Eric Messner, Chief Executive Officer at...
by John Conrad | Mar 22, 2023 | iBIO News
iBIO has opened student applications for the 2023 Illinois BioGENEius Competition and is welcoming students from all over Illinois to apply and participate for top honors. This highly prestigious science competition seeks to recognize and reward excellence in...
by John Conrad | Mar 20, 2023 | iBIO News
The Illinois Biotechnology Innovation Organization (iBIO) is excited to announce the call for applications for the 2023 iBIO Showcase. The 2023 iBIO Showcase will be held on June 1, 2023 at Fulton Labs (400 N Aberdeen St, Chicago, IL). This annual event brings...
by John Conrad | Mar 16, 2023 | Member News
Seventy years is a long time, and it’s been a fruitful one for CSL Behring, the global biotechnology company with a location along Illinois Route 50 in Bourbonnais Township. CSL Behring broke ground in 1951 on the site it still occupies in a then-$14 million...
by John Conrad | Mar 16, 2023 | iBIO in the News
PCI Pharma Services, a Philadelphia contract drug manufacturer, is investing $50 million into a new manufacturing facility in Rockford that’s expected to create about 250 jobs. The 200,000-square-foot site will enhance the company’s ability to create a...
by John Conrad | Mar 15, 2023 | Member News
In recent years, the biotech industry in Illinois has witnessed steady growth, with more and more companies choosing the state as their manufacturing hub. This can be attributed to the state’s well-developed infrastructure and skilled workforce. Amidst this...
by John Conrad | Mar 10, 2023 | Policy News
Yesterday President Biden unveiled his 2024 budget request that includes drastic changes to the Medicare program. The budget looks to immediately build off the Inflation Reduction Act by rapidly expanding the number of drugs that will be negotiated and decreasing the...
by John Conrad | Mar 10, 2023 | iBIO News
Yesterday, patients and members of the rare disease community joined iBIO and our members in Springfield to discuss the challenges rare disease patients face in Illinois. Attendees learned from Dr. VK Gadi about the importance of diversity in Clinical Trials and how...
by John Conrad | Mar 4, 2023 | Bill Report
Legislative Information System 3/4/2023 103rd General Assembly 8:28:19 AM All Bills (Bill Order) Both Chambers 2023 HB1 La Shawn K. Ford ILLINOIS CURE ACT 02/21/2023 House Assigned to Executive Committee **** HB 1 Executive Committee Hearing Mar 8 2023 10:00AM Capitol...
by John Conrad | Mar 2, 2023 | Member News
Today, the Chan Zuckerberg Initiative (CZI) announced the launch of a new biomedical research hub in Chicago, Illinois that will bring together leading scientific and technology institutions with the goal of solving grand scientific challenges on a 10- to 15-year time...
